327 related articles for article (PubMed ID: 33374737)
1. Pathogenic Impacts of Dysregulated Polycomb Repressive Complex Function in Hematological Malignancies.
Kaito S; Iwama A
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374737
[TBL] [Abstract][Full Text] [Related]
2. Deregulated Polycomb functions in myeloproliferative neoplasms.
Sashida G; Oshima M; Iwama A
Int J Hematol; 2019 Aug; 110(2):170-178. PubMed ID: 30706327
[TBL] [Abstract][Full Text] [Related]
3. Multifaceted role of the polycomb-group gene EZH2 in hematological malignancies.
Sashida G; Iwama A
Int J Hematol; 2017 Jan; 105(1):23-30. PubMed ID: 27830540
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic roles of enhancer of zeste homolog 1/2 in hematological malignancies.
Nakagawa M; Kitabayashi I
Cancer Sci; 2018 Aug; 109(8):2342-2348. PubMed ID: 29845708
[TBL] [Abstract][Full Text] [Related]
5. Polycomb complexes PRC1 and their function in hematopoiesis.
Vidal M; Starowicz K
Exp Hematol; 2017 Apr; 48():12-31. PubMed ID: 28087428
[TBL] [Abstract][Full Text] [Related]
6. Polycomb repressive complexes in hematological malignancies.
Iwama A
Blood; 2017 Jul; 130(1):23-29. PubMed ID: 28483764
[TBL] [Abstract][Full Text] [Related]
7. Polycomb-group proteins in hematopoietic stem cell regulation and hematopoietic neoplasms.
Radulović V; de Haan G; Klauke K
Leukemia; 2013 Mar; 27(3):523-33. PubMed ID: 23257781
[TBL] [Abstract][Full Text] [Related]
8. Ezh2 loss in hematopoietic stem cells predisposes mice to develop heterogeneous malignancies in an Ezh1-dependent manner.
Mochizuki-Kashio M; Aoyama K; Sashida G; Oshima M; Tomioka T; Muto T; Wang C; Iwama A
Blood; 2015 Sep; 126(10):1172-83. PubMed ID: 26219303
[TBL] [Abstract][Full Text] [Related]
9. A Noncanonical Function of Polycomb Repressive Complexes Promotes Human Cytomegalovirus Lytic DNA Replication and Serves as a Novel Cellular Target for Antiviral Intervention.
Svrlanska A; Reichel A; Schilling EM; Scherer M; Stamminger T; Reuter N
J Virol; 2019 May; 93(9):. PubMed ID: 30814291
[TBL] [Abstract][Full Text] [Related]
10. Novel orally bioavailable EZH1/2 dual inhibitors with greater antitumor efficacy than an EZH2 selective inhibitor.
Honma D; Kanno O; Watanabe J; Kinoshita J; Hirasawa M; Nosaka E; Shiroishi M; Takizawa T; Yasumatsu I; Horiuchi T; Nakao A; Suzuki K; Yamasaki T; Nakajima K; Hayakawa M; Yamazaki T; Yadav AS; Adachi N
Cancer Sci; 2017 Oct; 108(10):2069-2078. PubMed ID: 28741798
[TBL] [Abstract][Full Text] [Related]
11. Emerging role of noncanonical polycomb repressive complexes in normal and malignant hematopoiesis.
Isshiki Y; Iwama A
Exp Hematol; 2018 Dec; 68():10-14. PubMed ID: 30554637
[TBL] [Abstract][Full Text] [Related]
12. Critical Roles of Polycomb Repressive Complexes in Transcription and Cancer.
Dong GJ; Xu JL; Qi YR; Yuan ZQ; Zhao W
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076977
[TBL] [Abstract][Full Text] [Related]
13. MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells.
Rajabi H; Hiraki M; Kufe D
Oncogene; 2018 Apr; 37(16):2079-2088. PubMed ID: 29379165
[TBL] [Abstract][Full Text] [Related]
14. The Role of Polycomb Group Protein BMI1 in DNA Repair and Genomic Stability.
Fitieh A; Locke AJ; Motamedi M; Ismail IH
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804165
[TBL] [Abstract][Full Text] [Related]
15. Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies.
Khan SN; Jankowska AM; Mahfouz R; Dunbar AJ; Sugimoto Y; Hosono N; Hu Z; Cheriyath V; Vatolin S; Przychodzen B; Reu FJ; Saunthararajah Y; O'Keefe C; Sekeres MA; List AF; Moliterno AR; McDevitt MA; Maciejewski JP; Makishima H
Leukemia; 2013 Jun; 27(6):1301-9. PubMed ID: 23486531
[TBL] [Abstract][Full Text] [Related]
16. Polycomb repressive complex 2 (PRC2) suppresses Eμ-myc lymphoma.
Lee SC; Phipson B; Hyland CD; Leong HS; Allan RS; Lun A; Hilton DJ; Nutt SL; Blewitt ME; Smyth GK; Alexander WS; Majewski IJ
Blood; 2013 Oct; 122(15):2654-63. PubMed ID: 23982173
[TBL] [Abstract][Full Text] [Related]
17. Polycomb genes and cancer: time for clinical application?
Crea F; Paolicchi E; Marquez VE; Danesi R
Crit Rev Oncol Hematol; 2012 Aug; 83(2):184-93. PubMed ID: 22112692
[TBL] [Abstract][Full Text] [Related]
18. The polycomb group gene product Ezh2 regulates proliferation and differentiation of murine hepatic stem/progenitor cells.
Aoki R; Chiba T; Miyagi S; Negishi M; Konuma T; Taniguchi H; Ogawa M; Yokosuka O; Iwama A
J Hepatol; 2010 Jun; 52(6):854-63. PubMed ID: 20395008
[TBL] [Abstract][Full Text] [Related]
19. The role of the polycomb repressive complex pathway in T and NK cell lymphoma: biological and prognostic implications.
Kim SH; Yang WI; Min YH; Ko YH; Yoon SO
Tumour Biol; 2016 Feb; 37(2):2037-47. PubMed ID: 26337274
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells.
Fiskus W; Pranpat M; Balasis M; Herger B; Rao R; Chinnaiyan A; Atadja P; Bhalla K
Mol Cancer Ther; 2006 Dec; 5(12):3096-104. PubMed ID: 17172412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
